UC studies tobacco use, cancer connection
Research shows tobacco use changes metabolism of kidney cancer, may lead to targeted treatments
Researchers at the University of Cincinnati have identified new clues into ways tobacco use impacts patients with kidney cancer.
The study, published in the Journal of Clinical Investigation, provides the first steps in developing personalized treatments for patients with this type of cancer.
Expanding on previous work that identified the mutations of kidney cancer cells, this study reveals metabolic fingerprints that distinguish cancers from nonsmokers compared to smokers.
Maria Czyzyk-Krzeska, MD, PhD, professor in the UC Department of Cancer Biology, who studies kidney cancer within the UC Cancer Center. Photo credit/UC Creative + Brand
“Standard analysis of mutations may not have detected the effects of tobacco smoking in kidney cancer, so these results and this study provides important steps toward new and better therapeutic strategies for kidney cancers in both smoking and nonsmoking populations,” says Maria Czyzyk-Krzeska, MD, PhD, professor in the UC Department of Cancer Biology.
The disease studied, called “clear cell renal cell carcinoma,” is the most common type of kidney cancer, but there are few chemotherapy options for advanced cancers, she says.
A multidisciplinary team of UC researchers led by Czyzyk-Krzeska in Cancer Biology, Jarek Meller, PhD, in Environmental and Public Health Sciences, and Julio Landero Figueroa, PhD, in Chemistry, analyzed tissues of patients who were tobacco users as well as those who were not, uncovering the widespread effects of smoking in this form of kidney cancer.
“Importantly, this integrated approach was key to identifying the major metabolic reprogramming in energy and biosynthesis, associated with the presence of cadmium and inorganic arsenic found in cigarettes, together with a distinct signature of copper in tumors from tobacco smokers,” says Maria Czyzyk-Krzeska.
Clear cell renal cell carcinoma, a type of kidney cancer. Photo credit/Wikipedia
The data show that tumors from longtime smokers represent a separate metabolic subtype of kidney cancer with different weaknesses and which could require a dedicated treatment strategy.
“There is a need for an in-depth analysis of metabolic subtypes of these cancers to establish the best way to treat each individual tumor,” she says. “This is one of the earliest studies to establish that this type of analysis is necessary. Personalized, or precision medicine, has the promise of offering a specific and unique therapy based on the molecular landscape of each patient’s cancer.
“This has huge potential to change outcomes for patients, leading to better and longer lives.”
Featured photo of cigarette use courtesy of Unsplash.
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Co-authors on this study include James Reigle, co-first author, Dina Secic, Collin Wetzel, David Plas, John “Tom” Cunningham, Nicholas Talbot, Megan Bischoff, Yongzhen Zhang, Yuanwei Zang, Johnson Chu, UC Department of Cancer Biology; Jarek Meller, Mario Medvedovic, Jacek Biesiada, Behrouz Shamsaei and Xiang Zhang, UC Department of Environmental Public Health Sciences; Julio Landero Figueroa, UC Department of Chemistry; Charuhas Thakar, UC Department of Medicine, Division of Nephrology; Krishnanath Gaitonde and Abhinav Sidana, UC Department of Surgery, Division of Urology; Hai Bui, Cincinnati Department of Veterans Affairs; Qing Zhang, UNC at Chapel Hill Department of Pathology and Laboratory Medicine; and Laura Schmidt and W. Marston Linehan, National Cancer Institute. UC oncologist Shuchi Gulati is a clinical partner on the team.
Czyzyk-Krzeska cites no conflict of interest.
Related Stories
When grief doesn't end: Nursing PhD students bring a classroom theory to Ohio families
October 29, 2026
Most of us think of grief as something with an ending. A loss happens, it hurts, and over time the hurt fades. For many parents of children with developmental disabilities, it doesn't work that way. The sadness can quiet down for months or years and then come back. It might return on the first day of kindergarten, at a cousin's wedding, at a high school graduation, or on the day a young adult ages out of school services. Nurses and researchers have a name for this: chronic sorrow. Last October, two University of Cincinnati College of Nursing PhD students helped bring that name to a room of families, people with disabilities and the professionals who support them.
UC student's NFL internship leads to $20,000 gift to reduce loan burden
October 29, 2026
University of Cincinnati athletic training graduate student Savannah Posey interned with the Buffalo Bills during training camp and received a surprise $20,000 gift toward her student loans from safety C.J. Gardner-Johnson through his Ceedy Cares Foundation.
UC celebrates a century of Homecoming with a parade, pride and signature win over Texas Tech
October 28, 2026
The University of Cincinnati celebrated its 100th Homecoming. The Cincinnati Bearcats defeated No. 8-ranked Texas Tech, 37-24, before a sell-out audience in Nippert Stadium. Photos of Homecoming activities show Bearcats Pride at its finest.